Dashboard
Healthy long term growth as Net Sales has grown by an annual rate of 19.33% and Operating profit at 52.64%
The company has declared Positive results for the last 3 consecutive quarters
With ROE of 14.94%, it has a very attractive valuation with a 2.13 Price to Book Value
Market Beating Performance
Total Returns (Price + Dividend) 
Dexterra Group, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

Dexterra Group Hits Day High with 7.22% Surge in Stock Price
Dexterra Group, Inc. has demonstrated notable market activity, achieving an intraday high and outperforming the S&P/TSX 60. Over the past year, the company has delivered substantial returns and reported impressive financial metrics, including significant profit growth and strong operating cash flow, reflecting its robust operational efficiency and healthy growth trajectory.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2017
Shareholding Compare (%holding) 
Foreign Institutions
Held in 0 Schemes (0%)
Held by 1 Foreign Institutions (0.06%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
YoY Growth in quarter ended Jun 2025 is -1.70% vs -5.30% in Jun 2024
YoY Growth in quarter ended Jun 2025 is -3.28% vs 43.53% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 8.11% vs -4.50% in Dec 2023
YoY Growth in year ended Dec 2024 is 4.75% vs 867.57% in Dec 2023






